应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ATRC AtriCure公司
交易中 03-11 10:45:19 EDT
29.22
+0.04
+0.14%
最高
29.28
最低
28.69
成交量
5.55万
今开
28.91
昨收
29.18
日振幅
2.00%
总市值
14.53亿
流通市值
14.01亿
总股本
4,972万
成交额
160.47万
换手率
0.12%
流通股本
4,793万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
AtriCure公司公布2025年第四季度及全年初步业绩,并展望2026年财务前景
美股速递 · 01-12
AtriCure公司公布2025年第四季度及全年初步业绩,并展望2026年财务前景
AtriCure盘中异动 临近午盘股价大涨5.08%
市场透视 · 2025-11-22
AtriCure盘中异动 临近午盘股价大涨5.08%
AtriCure 2025财年Q3业绩会总结及问答精华:创新产品与国际市场推动增长
业绩会速递 · 2025-10-31
AtriCure 2025财年Q3业绩会总结及问答精华:创新产品与国际市场推动增长
AtriCure盘中异动 股价大跌5.11%报33.45美元
市场透视 · 2025-10-01
AtriCure盘中异动 股价大跌5.11%报33.45美元
AtriCure盘中异动 大幅下跌5.11%
市场透视 · 2025-03-04
AtriCure盘中异动 大幅下跌5.11%
AtriCure盘中异动 股价大跌5.03%报38.88美元
市场透视 · 2025-02-19
AtriCure盘中异动 股价大跌5.03%报38.88美元
AtriCure2024财年实现净利润-44.70百万美元,同比减少46.85%
市场透视 · 2025-02-16
AtriCure2024财年实现净利润-44.70百万美元,同比减少46.85%
AtriCure盘中异动 早盘股价大跌6.94%报39.42美元
市场透视 · 2025-02-13
AtriCure盘中异动 早盘股价大跌6.94%报39.42美元
AtriCure公司预测2025财年调整后每股收益为$(0.57)-$(0.64); 收入为5.17亿至5.27亿美元。
财报速递 · 2025-02-13
AtriCure公司预测2025财年调整后每股收益为$(0.57)-$(0.64); 收入为5.17亿至5.27亿美元。
AtriCure 2024年第四季度调整后每股亏损$0.08,优于预期的$0.23,销售额$1.243亿,超过预期的$1.21842亿
财报速递 · 2025-02-13
AtriCure 2024年第四季度调整后每股亏损$0.08,优于预期的$0.23,销售额$1.243亿,超过预期的$1.21842亿
AtriCure盘中异动 早盘股价大跌5.14%
市场透视 · 2025-01-30
AtriCure盘中异动 早盘股价大跌5.14%
阿布扎比公布数字战略三年行动计划,投入35亿美元推动政府AI转型
市场资讯 · 2025-01-22
阿布扎比公布数字战略三年行动计划,投入35亿美元推动政府AI转型
AtriCure盘中异动 股价大涨5.04%报36.44美元
市场透视 · 2025-01-16
AtriCure盘中异动 股价大涨5.04%报36.44美元
AtriCure盘中异动 早盘快速上涨5.05%
市场透视 · 2025-01-14
AtriCure盘中异动 早盘快速上涨5.05%
AtriCure盘中异动 股价大涨5.00%报32.98美元
市场透视 · 2025-01-13
AtriCure盘中异动 股价大涨5.00%报32.98美元
AtriCure盘中异动 股价大跌5.02%
市场透视 · 2025-01-11
AtriCure盘中异动 股价大跌5.02%
AtriCure盘中异动 股价大涨6.18%
市场透视 · 2025-01-06
AtriCure盘中异动 股价大涨6.18%
AtriCure盘中异动 大幅拉升5.00%报31.92美元
市场透视 · 2025-01-04
AtriCure盘中异动 大幅拉升5.00%报31.92美元
AtriCure盘中异动 下午盘大幅跳水5.01%报34.49美元
市场透视 · 2024-12-06
AtriCure盘中异动 下午盘大幅跳水5.01%报34.49美元
AtriCure盘中异动 大幅拉升5.14%
市场透视 · 2024-11-06
AtriCure盘中异动 大幅拉升5.14%
加载更多
公司概况
公司名称:
AtriCure公司
所属市场:
NASDAQ
上市日期:
--
主营业务:
AtriCure, Inc.于2000年10月31日在特拉华州注册成立。该公司是房颤、左心耳管理和术后疼痛管理手术治疗和疗法的领先创新者。该公司的心脏消融和左心耳管理产品供医生在心脏直视和微创手术中使用。该公司的疼痛管理解决方案被医生用于在心脏、胸部或截肢手术中冷冻神经。该公司用于疼痛管理的cryoICE冷冻球和cryoXT探头可暂时缓解术后疼痛,使患者的身体在手术后愈合,同时神经再生和感觉恢复。该公司通过其在美国、德国、法国、英国、比荷卢经济联盟地区、澳大利亚和加拿大的直销团队向医疗中心销售产品。该公司还通过分销商销售其产品,分销商又将其产品出售给其他国际市场的医疗中心。
发行价格:
--
{"stockData":{"symbol":"ATRC","market":"US","secType":"STK","nameCN":"AtriCure公司","latestPrice":29.22,"timestamp":1773240303486,"preClose":29.18,"halted":0,"volume":55459,"delay":0,"changeRate":0.0013708019191226576,"floatShares":47931070,"shares":49716988,"eps":-0.239748,"marketStatus":"交易中","change":0.04,"latestTime":"03-11 10:45:19 EDT","open":28.91,"high":29.275,"low":28.69,"amount":1604652.7025239998,"amplitude":0.020048,"askPrice":29.39,"askSize":100,"bidPrice":29.1,"bidSize":8,"shortable":3,"etf":0,"ttmEps":-0.239748,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773259200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1123214400000,"exchange":"NASDAQ","adjPreClose":29.18,"preHourTrading":{"tag":"盘前","latestPrice":29.15,"preClose":29.18,"latestTime":"09:29 EDT","volume":746,"amount":21868.10972,"timestamp":1773235799999,"change":-0.03,"changeRate":-0.001028,"amplitude":0.043866},"postHourTrading":{"tag":"盘后","latestPrice":29.18,"preClose":29.18,"latestTime":"16:10 EDT","volume":11116,"amount":324364.88,"timestamp":1773173404971,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.55137,"impliedVol":0.8205,"impliedVolPercentile":0.9602},"requestUrl":"/m/hq/s/ATRC","defaultTab":"news","newsList":[{"id":"1189977415","title":"AtriCure公司公布2025年第四季度及全年初步业绩,并展望2026年财务前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1189977415","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189977415?lang=zh_cn&edition=full","pubTime":"2026-01-12 23:28","pubTimestamp":1768231694,"startTime":"0","endTime":"0","summary":"AtriCure公司近日披露了2025财年第四季度及全年初步业绩报告,同时向市场公布了针对2026财年的财务展望。这一举措为投资者提供了评估该公司未来增长轨迹的关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ATRC"],"gpt_icon":0},{"id":"2585177136","title":"AtriCure盘中异动 临近午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585177136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585177136?lang=zh_cn&edition=full","pubTime":"2025-11-22 00:38","pubTimestamp":1763743123,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日00时38分,AtriCure股票出现波动,股价急速上涨5.08%。截至发稿,该股报34.94美元/股,成交量19.4614万股,换手率0.39%,振幅4.86%。AtriCure股票所在的医疗设备行业中,整体涨幅为0.52%。AtriCure公司简介:AtriCure Inc 是心房颤动 ,左心耳 管理和术后疼痛管理的外科治疗和疗法的创新者,并通过其直销团队和分销商向医疗中心销售其产品。疼痛管理解决方案由医生在心胸外科或胸外科手术期间用于冻结神经。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122003843951307aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122003843951307aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRC","BK4082"],"gpt_icon":0},{"id":"1164964235","title":"AtriCure 2025财年Q3业绩会总结及问答精华:创新产品与国际市场推动增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1164964235","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164964235?lang=zh_cn&edition=full","pubTime":"2025-10-31 01:36","pubTimestamp":1761845789,"startTime":"0","endTime":"0","summary":"调整后EBITDA预计为5500万至5700万美元,调整后每股亏损预计为0.23至0.26美元。美国市场收入增长14.5%,国际市场收入增长22%。EPiSense业务的增长主要依赖于PFA技术的非响应患者转向其他治疗方案,目前已有部分患者转诊,但尚未显著推动收入增长。此外,LEAPS试验将进一步巩固AtriClip的市场地位。AtriCure在2025财年第三季度表现强劲,得益于创新产品的成功推出和国际市场的增长。管理层对未来充满信心,预计通过临床试验和市场渗透进一步推动增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRC"],"gpt_icon":0},{"id":"2572514709","title":"AtriCure盘中异动 股价大跌5.11%报33.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572514709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572514709?lang=zh_cn&edition=full","pubTime":"2025-10-01 22:47","pubTimestamp":1759330067,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日22时47分,AtriCure股票出现异动,股价快速跳水5.11%。截至发稿,该股报33.45美元/股,成交量7.3678万股,换手率0.15%,振幅5.09%。AtriCure股票所在的医疗设备行业中,整体跌幅为0.83%。AtriCure公司简介:AtriCure Inc 是心房颤动 ,左心耳 管理和术后疼痛管理的外科治疗和疗法的创新者,并通过其直销团队和分销商向医疗中心销售其产品。疼痛管理解决方案由医生在心胸外科或胸外科手术期间用于冻结神经。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001224747a6aa16c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001224747a6aa16c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","ATRC"],"gpt_icon":0},{"id":"2517605409","title":"AtriCure盘中异动 大幅下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517605409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517605409?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:53","pubTimestamp":1741103606,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时53分,AtriCure股票出现波动,股价快速下跌5.11%。截至发稿,该股报36.97美元/股,成交量5.8676万股,换手率0.12%,振幅4.00%。AtriCure股票所在的医疗设备行业中,整体跌幅为1.35%。AtriCure公司简介:AtriCure Inc 是心房颤动 ,左心耳 管理和术后疼痛管理的外科治疗和疗法的创新者,并通过其直销团队和分销商向医疗中心销售其产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304235327a25f1b2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304235327a25f1b2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRC","BK4082"],"gpt_icon":0},{"id":"2512162011","title":"AtriCure盘中异动 股价大跌5.03%报38.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512162011?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:22","pubTimestamp":1739895731,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时22分,AtriCure股票出现波动,股价快速下跌5.03%。截至发稿,该股报38.88美元/股,成交量20.188万股,换手率0.41%,振幅4.29%。AtriCure股票所在的医疗设备行业中,整体涨幅为0.18%。其相关个股中,Innovative Eyewear Inc C/Wts 16/08/2027 Ser A、Predictive Oncology Inc.、美华国际涨幅较大,Predictive Oncology Inc.、Sharps Technology Inc.、Glucotrack, Inc.较为活跃,换手率分别为34.91%、12.91%、7.90%,振幅较大的相关个股有Innovative Eyewear Inc C/Wts 16/08/2027 Ser A、美华国际、Nexgel Inc C/Wts 27/12/2026 ,振幅分别为17.39%、14.41%、13.05%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190022119627aac1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190022119627aac1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRC","BK4082"],"gpt_icon":0},{"id":"2511407670","title":"AtriCure2024财年实现净利润-44.70百万美元,同比减少46.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511407670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511407670?lang=zh_cn&edition=full","pubTime":"2025-02-16 00:01","pubTimestamp":1739635293,"startTime":"0","endTime":"0","summary":"2月16日,AtriCure公布财报,公告显示公司2024财年净利润为-44.70百万美元,同比减少46.85%;其中营业收入为4.65亿美元,同比增加16.54%,每股基本收益为-0.95美元。从资产负债表来看,AtriCure总负债1.48亿美元,其中短期债务2.81百万美元,资产负债比为4.12,流动比率为0.04。机构评级:截至2025年2月16日,当前有9家机构对AtriCure目标价做出预测,其中目标均价为54.22美元,其中最低目标价为45.00美元,最高目标价为66.00美元。其产品线包括冷冻、软组织解剖、射频消融起搏和传感等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000200a24729fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000200a24729fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRC"],"gpt_icon":0},{"id":"2511525158","title":"AtriCure盘中异动 早盘股价大跌6.94%报39.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525158?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:32","pubTimestamp":1739457179,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时32分,AtriCure股票出现异动,股价急速下跌6.94%。截至发稿,该股报39.42美元/股,成交量4.2504万股,换手率0.09%,振幅1.78%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。AtriCure股票所在的医疗设备行业中,整体跌幅为0.40%。其相关个股中,Avinger, Inc.、中进医疗、Akoya Biosciences, Inc.涨幅较大,Avinger, Inc.、Sharps Technology Inc.、Glucotrack, Inc.较为活跃,换手率分别为351.72%、8.94%、1.41%,振幅较大的相关个股有Avinger, Inc.、Sharps Technology Inc.、AtriCure,振幅分别为8.89%、6.70%、6.28%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223300a244ab9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223300a244ab9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRC","BK4082"],"gpt_icon":0},{"id":"1145550810","title":"AtriCure公司预测2025财年调整后每股收益为$(0.57)-$(0.64); 收入为5.17亿至5.27亿美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=1145550810","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145550810?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:06","pubTimestamp":1739394387,"startTime":"0","endTime":"0","summary":"AtriCure公司预测2025财年调整后每股收益为$(0.57)-$(0.64); 收入为5.17亿至5.27亿美元。以上内容来自Benzinga Earnings专栏,原文如下:AtriCure Sees FY25 Adj. EPS ($0.57)-($0.64); Revenue $517M-$527M.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRC"],"gpt_icon":0},{"id":"1194653199","title":"AtriCure 2024年第四季度调整后每股亏损$0.08,优于预期的$0.23,销售额$1.243亿,超过预期的$1.21842亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1194653199","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194653199?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:04","pubTimestamp":1739394255,"startTime":"0","endTime":"0","summary":"AtriCure 报告其季度每股亏损$0.08,优于分析师预期的$0.23,超出65.22%。这一结果较去年同期每股亏损$0.21增加了61.9%。公司报告其季度销售额为$1.243亿,超过分析师预期的$1.21842亿,增幅2.02%。以上内容来自Benzinga Earnings专栏,原文如下:AtriCure reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 65.22 percent. This is a 61.9 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $124.300 million which beat the analyst consensus estimate of $121.842 million by 2.02 percent. This ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"AtriCure 2024年第四季度调整后每股亏损$0.08,优于预期的$0.23,销售额$1.243亿,超过预期的$1.21842亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRC"],"gpt_icon":0},{"id":"2507620506","title":"AtriCure盘中异动 早盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507620506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507620506?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:50","pubTimestamp":1738252250,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时50分,AtriCure股票出现异动,股价急速下挫5.14%。截至发稿,该股报40.22美元/股,成交量13.58万股,换手率0.28%,振幅5.94%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。AtriCure股票所在的医疗设备行业中,整体涨幅为1.14%。其相关个股中,Avinger, Inc.、Bionano Genomics, Inc.、Sharps Technology Inc C/Wts 涨幅较大,Glucotrack, Inc.、Sharps Technology Inc.、Avinger, Inc.较为活跃,换手率分别为250.74%、86.75%、33.77%,振幅较大的相关个股有Avinger, Inc.、Bionano Genomics, Inc.、Sharps Technology Inc C/Wts ,振幅分别为24.15%、15.58%、15.38%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302350509876baf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302350509876baf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","ATRC"],"gpt_icon":0},{"id":"2505545147","title":"阿布扎比公布数字战略三年行动计划,投入35亿美元推动政府AI转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2505545147","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505545147?lang=zh_cn&edition=full","pubTime":"2025-01-22 09:27","pubTimestamp":1737509220,"startTime":"0","endTime":"0","summary":"财联社1月22日讯 阿联酋最大酋长国——阿布扎比政府宣布了“阿布扎比政府数字战略2025-2027”,推动当地向人工智能政府转型。 据阿布扎比政府媒体办公室刊登的新闻稿,该战略由阿布扎比政府支持部与阿布扎比政府实体合作实施,旨在将该酋长国定位为人工智能驱动型政府的全球领导者,并将在2025-2027年期间拨款130亿迪拉姆,以促进当地的创新和技术采用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-01-22/doc-inefvcyf7220628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ATRC","BK4082"],"gpt_icon":0},{"id":"2503246679","title":"AtriCure盘中异动 股价大涨5.04%报36.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503246679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503246679?lang=zh_cn&edition=full","pubTime":"2025-01-16 03:41","pubTimestamp":1736970111,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日03时41分,AtriCure股票出现波动,股价快速拉升5.04%。截至发稿,该股报36.44美元/股,成交量25.8045万股,换手率0.53%,振幅4.67%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。AtriCure股票所在的医疗设备行业中,整体涨幅为4.12%。其相关个股中,Microbot Medical Inc.、Nexgel, Inc、Nephros, Inc.涨幅较大,Glucotrack, Inc.、Microbot Medical Inc.、Avinger, Inc.较为活跃,换手率分别为603.11%、17.21%、8.59%,振幅较大的相关个股有Microbot Medical Inc.、Glucotrack, Inc.、Innovative Eyewear Inc C/Wts 16/08/2027 Ser A,振幅分别为24.03%、19.92%、19.26%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116034151a223449b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116034151a223449b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","ATRC"],"gpt_icon":0},{"id":"2503570955","title":"AtriCure盘中异动 早盘快速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503570955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503570955?lang=zh_cn&edition=full","pubTime":"2025-01-14 23:38","pubTimestamp":1736869092,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日23时38分,AtriCure股票出现异动,股价快速拉升5.05%。截至发稿,该股报36.13美元/股,成交量11.8665万股,换手率0.24%,振幅4.65%。AtriCure股票所在的医疗设备行业中,整体涨幅为0.05%。其相关个股中,中进医疗、Sharps Technology Inc C/Wts 、Nephros, Inc.涨幅较大,Glucotrack, Inc.、Avinger, Inc.、Microbot Medical Inc.较为活跃,换手率分别为363.16%、30.62%、6.46%,振幅较大的相关个股有中进医疗、Akoya Biosciences, Inc.、Sharps Technology Inc C/Wts ,振幅分别为13.04%、11.60%、11.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114233812abaabcee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114233812abaabcee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRC","BK4082"],"gpt_icon":0},{"id":"2503839575","title":"AtriCure盘中异动 股价大涨5.00%报32.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503839575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503839575?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778683,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分,AtriCure股票出现波动,股价大幅上涨5.00%。截至发稿,该股报32.98美元/股,成交量9519股,换手率0.02%,振幅0.45%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。AtriCure股票所在的医疗设备行业中,整体跌幅为0.40%。其相关个股中,Glucotrack, Inc.、AtriCure、Zentek Ltd.涨幅较大,Glucotrack, Inc.、Microbot Medical Inc.、Ekso Bionics Holdings, Inc.较为活跃,换手率分别为1656.47%、1.15%、0.93%,振幅较大的相关个股有Glucotrack, Inc.、Akoya Biosciences, Inc.、Microbot Medical Inc.,振幅分别为2.99%、1.98%、1.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223123aba9303e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223123aba9303e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","ATRC"],"gpt_icon":0},{"id":"2502976548","title":"AtriCure盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502976548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502976548?lang=zh_cn&edition=full","pubTime":"2025-01-11 01:19","pubTimestamp":1736529577,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日01时19分,AtriCure股票出现异动,股价快速下跌5.02%。截至发稿,该股报31.97美元/股,成交量46.344万股,换手率0.95%,振幅5.59%。AtriCure股票所在的医疗设备行业中,整体涨幅为0.03%。其相关个股中,Akoya Biosciences, Inc.、Nexgel Inc C/Wts 27/12/2026 、Daxor Corporation涨幅较大,Glucotrack, Inc.、Akoya Biosciences, Inc.、Microbot Medical Inc.较为活跃,换手率分别为287.35%、37.10%、12.12%,振幅较大的相关个股有Innovative Eyewear Inc C/Wts 16/08/2027 Ser A、Akoya Biosciences, Inc.、Nexgel Inc C/Wts 27/12/2026 ,振幅分别为37.11%、27.07%、23.85%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111011937a21d34b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111011937a21d34b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4082","BK4121","AKYA","ATRC"],"gpt_icon":0},{"id":"2501425568","title":"AtriCure盘中异动 股价大涨6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501425568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501425568?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:32","pubTimestamp":1736173945,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时32分,AtriCure股票出现异动,股价快速拉升6.18%。截至发稿,该股报34.01美元/股,成交量2.4491万股,换手率0.05%,振幅5.42%。AtriCure股票所在的医疗设备行业中,整体跌幅为0.05%。其相关个股中,Ekso Bionics Holdings, Inc.、Microbot Medical Inc.、Pro-Dex, Inc.涨幅较大,Microbot Medical Inc.、Ekso Bionics Holdings, Inc.、Glucotrack, Inc.较为活跃,换手率分别为167.44%、121.49%、26.13%,振幅较大的相关个股有Ekso Bionics Holdings, Inc.、Microbot Medical Inc.、Bionano Genomics, Inc.,振幅分别为8.29%、6.07%、4.96%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223225985ce77b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223225985ce77b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRC","BK4082"],"gpt_icon":0},{"id":"2500129759","title":"AtriCure盘中异动 大幅拉升5.00%报31.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500129759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500129759?lang=zh_cn&edition=full","pubTime":"2025-01-04 04:50","pubTimestamp":1735937441,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日04时50分,AtriCure股票出现波动,股价快速上涨5.00%。截至发稿,该股报31.92美元/股,成交量29.0928万股,换手率0.60%,振幅5.00%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。AtriCure股票所在的医疗设备行业中,整体涨幅为0.94%。其相关个股中,Microbot Medical Inc.、Sharps Technology Inc C/Wts 、Predictive Oncology Inc.涨幅较大,Microbot Medical Inc.、Bionano Genomics, Inc.、Predictive Oncology Inc.较为活跃,换手率分别为106.81%、81.78%、56.03%,振幅较大的相关个股有Microbot Medical Inc.、Predictive Oncology Inc.、Sharps Technology Inc C/Wts ,振幅分别为96.49%、69.57%、48.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010404504195f8082a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010404504195f8082a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRC","BK4082"],"gpt_icon":0},{"id":"2489549224","title":"AtriCure盘中异动 下午盘大幅跳水5.01%报34.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489549224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489549224?lang=zh_cn&edition=full","pubTime":"2024-12-06 03:43","pubTimestamp":1733427818,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日03时43分,AtriCure股票出现波动,股价快速下挫5.01%。截至发稿,该股报34.49美元/股,成交量15.5623万股,换手率0.32%,振幅5.15%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。AtriCure股票所在的医疗设备行业中,整体跌幅为0.45%。其相关个股中,Sharps Technology Inc C/Wts 、Pro-Dex, Inc.、Stevanato Group S.P.A.涨幅较大,Sharps Technology Inc.、Glucotrack, Inc.、Innovative Eyewear, Inc.较为活跃,换手率分别为289.11%、1.93%、1.90%,振幅较大的相关个股有Sharps Technology Inc.、Sharps Technology Inc C/Wts 、Nexgel Inc C/Wts 01/12/2026 ,振幅分别为29.74%、25.90%、18.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206034338a1d7275a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206034338a1d7275a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","ATRC"],"gpt_icon":0},{"id":"2481763566","title":"AtriCure盘中异动 大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481763566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481763566?lang=zh_cn&edition=full","pubTime":"2024-11-06 01:42","pubTimestamp":1730828574,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日01时42分,AtriCure股票出现波动,股价快速上涨5.14%。截至发稿,该股报35.39美元/股,成交量50.3107万股,换手率1.03%,振幅5.94%。AtriCure股票所在的医疗设备行业中,整体涨幅为1.06%。其相关个股中,Glucotrack, Inc.、Innovative Eyewear Inc C/Wts 16/08/2027 Ser A、Stevanato Group S.P.A.涨幅较大,Glucotrack, Inc.、Innovative Eyewear, Inc.、Avinger, Inc.较为活跃,换手率分别为31.66%、1.98%、1.92%,振幅较大的相关个股有Glucotrack, Inc.、Sharps Technology Inc C/Wts 、Nexgel Inc C/Wts 01/12/2026 ,振幅分别为111.21%、20.00%、19.79%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106014255a2191ca3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106014255a2191ca3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","ATRC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atricure.com","stockEarnings":[{"period":"1week","weight":-0.0725},{"period":"1month","weight":-0.2137},{"period":"3month","weight":-0.2914},{"period":"6month","weight":-0.2231},{"period":"1year","weight":-0.13},{"period":"ytd","weight":-0.2624}],"compareEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":-0.0195},{"period":"3month","weight":-0.0151},{"period":"6month","weight":0.0297},{"period":"1year","weight":0.208},{"period":"ytd","weight":-0.007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AtriCure, Inc.于2000年10月31日在特拉华州注册成立。该公司是房颤、左心耳管理和术后疼痛管理手术治疗和疗法的领先创新者。该公司的心脏消融和左心耳管理产品供医生在心脏直视和微创手术中使用。该公司的疼痛管理解决方案被医生用于在心脏、胸部或截肢手术中冷冻神经。该公司用于疼痛管理的cryoICE冷冻球和cryoXT探头可暂时缓解术后疼痛,使患者的身体在手术后愈合,同时神经再生和感觉恢复。该公司通过其在美国、德国、法国、英国、比荷卢经济联盟地区、澳大利亚和加拿大的直销团队向医疗中心销售产品。该公司还通过分销商销售其产品,分销商又将其产品出售给其他国际市场的医疗中心。","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.004663},{"month":2,"riseRate":0.380952,"avgChangeRate":-0.03771},{"month":3,"riseRate":0.52381,"avgChangeRate":-0.001061},{"month":4,"riseRate":0.6,"avgChangeRate":0.015808},{"month":5,"riseRate":0.55,"avgChangeRate":0.031953},{"month":6,"riseRate":0.75,"avgChangeRate":0.067723},{"month":7,"riseRate":0.5,"avgChangeRate":0.00817},{"month":8,"riseRate":0.45,"avgChangeRate":-0.006533},{"month":9,"riseRate":0.47619,"avgChangeRate":0.005352},{"month":10,"riseRate":0.52381,"avgChangeRate":0.000153},{"month":11,"riseRate":0.761905,"avgChangeRate":0.039994},{"month":12,"riseRate":0.666667,"avgChangeRate":0.039177}],"exchange":"NASDAQ","name":"AtriCure公司","nameEN":"AtriCure"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AtriCure公司(ATRC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供AtriCure公司(ATRC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"AtriCure公司,ATRC,AtriCure公司股票,AtriCure公司股票老虎,AtriCure公司股票老虎国际,AtriCure公司行情,AtriCure公司股票行情,AtriCure公司股价,AtriCure公司股市,AtriCure公司股票价格,AtriCure公司股票交易,AtriCure公司股票购买,AtriCure公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AtriCure公司(ATRC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供AtriCure公司(ATRC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}